SynthesisPharmacotherapy2022

Effects of GLP-1 receptor agonists on cardiovascular outcomes in patients with type 2 diabetes and chronic kidney disease: A systematic review and meta-analysis.

Michael Kelly et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.